A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Acute Lymphoblastic Leukemia · Non-hodgkin Lymphoma,B Cell

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Contact: Study coordinator (He Huang, PhD) · hehuangyu@126.com · 86-13605714822

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Ghent, Belgium · Paris, France

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Philadelphia Positive Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia, Adult

Abroad (travel likely)Recruiting

Tianjin, China

Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Suzhou, China · Suzhou, China

A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia

Acute Lymphoblastic Leukemia · Acute Leukemias · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Manchester, United Kingdom